Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae

  • Shanmugasundaram, Kumar (Department of Physiology, Critical Care and Sleep Medicine, All India Institute of Medical Sciences) ;
  • Talwar, Anjana (Department of Physiology, Critical Care and Sleep Medicine, All India Institute of Medical Sciences) ;
  • Madan, Karan (Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences) ;
  • Bade, Geetanjali (Department of Physiology, Critical Care and Sleep Medicine, All India Institute of Medical Sciences)
  • Received : 2021.08.22
  • Accepted : 2022.02.13
  • Published : 2022.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Post-tuberculosis (TB) sequelae is a commonly encountered clinical entity, especially in high TB burden countries. This may represent chronic anatomic sequelae of previously treated TB, with frequent symptomatic presentation. This pilot study was aimed to investigate the pulmonary functions and systemic inflammatory markers in patients with post-TB sequelae (PTBS) and to compare them with post-TB without sequelae (PTBWS) participants and healthy controls. Methods: A total of 30 participants were enrolled, PTBS (n=10), PTBWS (n=10), and healthy controls (n=10). Pulmonary function tests included spirometry and measurement of airway impedance by impulse oscillometry. Serum levels of matrix metalloproteinase (MMP)-1, transforming growth factor-β, and interferon-γ were estimated. Results: Slow vital capacity (SVC), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC, and peak expiratory flow were significantly lower in PTBS as compared to controls. SVC and FEV1 were significantly less in PTBS as compared to PTBWS. Total airway impedance (Z5), total airway resistance (R5), central airway resistance (R20), area of reactance (Ax), and resonant frequency (Fres) were significantly higher and respiratory reactance at 5 and 20 Hz (X5, X20) were significantly lower in PTBS as compared to PTBWS. Spirometry parameters correlated with impulse oscillometry parameters in PTBS. Serum MMP-1 level was significantly higher in PTBS as compared to other groups. Conclusion: Significant pulmonary function impairment was observed in PTBS, and raised serum MMP-1 levels compared with PTBWS and healthy controls. Follow-up pulmonary function testing is recommended after treatment of TB for early diagnosis and treatment of PTBS.

Keywords

Acknowledgement

We acknowledge all the participants who took part in this study.

References

  1. World Health Organization. Global tuberculosis report 2020 [Internet]. Geneva: World Health Organization; 2020 [cited 2021 Feb 8]. Available from: https://www.who.int/publications-detail-redirect/9789240013131.
  2. Rachow A, Ivanova O, Wallis R, Charalambous S, Jani I, Bhatt N, et al. TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol. BMC Pulm Med 2019;19:4. https://doi.org/10.1186/s12890-018-0777-3
  3. Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev 2018;27:170077. https://doi.org/10.1183/16000617.0077-2017
  4. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest 2007;131:1817-24. https://doi.org/10.1378/chest.06-2949
  5. Yakar HI, Gunen H, Pehlivan E, Aydogan S. The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis 2017;12:323-9. https://doi.org/10.2147/COPD.S116086
  6. Irfan M. Post-tuberculosis pulmonary function and noninfectious pulmonary disorders. Int J Mycobacteriol 2016;5 Suppl 1:S57. https://doi.org/10.1016/j.ijmyco.2016.08.015
  7. Chung KP, Chen JY, Lee CH, Wu HD, Wang JY, Lee LN, et al. Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis. Clinics (Sao Paulo) 2011;66:549-56. https://doi.org/10.1590/S1807-59322011000400005
  8. Casarini M, Ameglio F, Alemanno L, Zangrilli P, Mattia P, Paone G, et al. Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am J Respir Crit Care Med 1999;159:143-8. https://doi.org/10.1164/ajrccm.159.1.9803066
  9. Subbian S, Tsenova L, Kim MJ, Wainwright HC, Visser A, Bandyopadhyay N, et al. Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: a pilot study. PLoS One 2015;10:e0132249. https://doi.org/10.1371/journal.pone.0132249
  10. Christine T, Tarigan AP, Ananda FR. The correlation between levels of transforming growth factor-beta with pulmonary fibrosis in post pulmonary tuberculosis in Medan, North Sumatera - Indonesia. Open Access Maced J Med Sci 2019;7:2075-8. https://doi.org/10.3889/oamjms.2019.544
  11. Rhee CK, Yoo KH, Lee JH, Park MJ, Kim WJ, Park YB, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis 2013;17:67-75. https://doi.org/10.5588/ijtld.12.0351
  12. Brashier B, Salvi S. Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system. Breathe (Sheff) 2015;11:57-65. https://doi.org/10.1183/20734735.020514
  13. Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry: interpretation and practical applications. Chest 2014;146:841-7. https://doi.org/10.1378/chest.13-1875
  14. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 2019;200:e70-88. https://doi.org/10.1164/rccm.201908-1590ST
  15. Akkara SA, Shah AD, Adalja M, Akkara AG, Rathi A, Shah DN. Pulmonary tuberculosis: the day after. Int J Tuberc Lung Dis 2013;17:810-3. https://doi.org/10.5588/ijtld.12.0317
  16. Santra A, Dutta P, Manjhi R, Pothal S. Clinico-radiologic and spirometric profile of an Indian population with post-tuberculous obstructive airway disease. J Clin Diagn Res 2017;11:OC35-8.
  17. Gupta N, Sachdev A, Gupta D, Gupta S. Oscillometry: the future of estimating pulmonary functions. Karnataka Paediatr J 2020;35:79-87.
  18. Wei X, Shi Z, Cui Y, Mi J, Ma Z, Ren J, et al. Impulse oscillometry system as an alternative diagnostic method for chronic obstructive pulmonary disease. Medicine (Baltimore) 2017;96:e8543. https://doi.org/10.1097/MD.0000000000008543
  19. Elkington PT, Green JA, Emerson JE, Lopez-Pascua LD, Boyle JJ, O'Kane CM, et al. Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis. Am J Respir Cell Mol Biol 2007;37:431-7. https://doi.org/10.1165/rcmb.2007-0011OC
  20. Ugarte-Gil CA, Elkington P, Gilman RH, Coronel J, Tezera LB, Bernabe-Ortiz A, et al. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS One 2013;8:e61333. https://doi.org/10.1371/journal.pone.0061333
  21. Singh S, Kubler A, Singh UK, Singh A, Gardiner H, Prasad R, et al. Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. Antimicrob Agents Chemother 2014;58:4657-65. https://doi.org/10.1128/AAC.02141-13
  22. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011;208:1339-50. https://doi.org/10.1084/jem.20110551
  23. Yamauchi M, Kinjo T, Parrott G, Miyagi K, Haranaga S, Nakayama Y, et al. Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia. PLoS One 2020;15:e0227636. https://doi.org/10.1371/journal.pone.0227636
  24. Farr K, Ravindran R, Strnad L, Chang E, Chaisson LH, Yoon C, et al. Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV. PLoS One 2018;13:e0206119. https://doi.org/10.1371/journal.pone.0206119
  25. Koksal D, Unsal E, Poyraz B, Kaya A, Savas H, Sipit T, et al. The value of serum interferon-gamma level in the differential diagnosis of active and inactive pulmonary tuberculosis. Tuberk Toraks 2006;54:17-21.
  26. Vankayalapati R, Wizel B, Weis SE, Klucar P, Shams H, Samten B, et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003;36:24-8. https://doi.org/10.1086/344903
  27. Tsao TC, Huang CC, Chiou WK, Yang PY, Hsieh MJ, Tsao KC. Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis 2002;6:720-7.
  28. Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Belisle JT, Ellis ME, et al. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun 1999;67:4295-7. https://doi.org/10.1128/iai.67.8.4295-4297.1999